Katrien Brak is currently the Director of Process Chemistry at Septerna, a role they have held since 2025. Previously, Katrien served as Associate Director and Principal Scientist in Process Chemistry at Denali Therapeutics from 2022 to 2023, and as Senior Research Scientist at Gilead Sciences from 2016 to 2019. Their educational background includes a Ph.D. in Chemistry from the University of California, Berkeley, and a Bachelor of Science from the Massachusetts Institute of Technology. Throughout their career, Katrien has contributed to significant advancements in process chemistry and drug development.
This person is not in any teams
This person is not in any offices